Why does targeted growth factor receptor therapy sometimes fail to induce apoptosis in cancer cells despite initial success?

💡 Explanation

Cancer cells can develop resistance through checkpoint adaptation, bypassing the growth inhibition signal from targeted therapy. This occurs because alternative signaling pathways are activated, allowing cell cycle progression despite receptor blockade; therefore, apoptosis is not induced, rather than cell death resulting directly from drug efflux.

• Why does hypothyroidism sometimes persist despite adequate iodine intake in a patient with a functional thyroid gland?
• Why does acute hemolytic transfusion reaction (AHTR) cause severe kidney damage, despite immediate cessation of the incompatible transfusion?
• If a patient experiences increased interstitial fluid pressure within tissues surrounding a surgical wound, which consequence is most likely regarding lymphatic drainage?
• Why does a subsequent exposure to pollen provoke a stronger allergic reaction in sensitized individuals compared to the initial exposure?
• Why does pulsatile GnRH secretion improve fertility outcomes compared to continuous GnRH administration during assisted reproductive technology?
• Which outcome impedes nutrient regulation when taste bud damage occurs?